BR9806754A - Composições paroxetine. - Google Patents

Composições paroxetine.

Info

Publication number
BR9806754A
BR9806754A BR9806754-0A BR9806754A BR9806754A BR 9806754 A BR9806754 A BR 9806754A BR 9806754 A BR9806754 A BR 9806754A BR 9806754 A BR9806754 A BR 9806754A
Authority
BR
Brazil
Prior art keywords
paroxetine
solutions
paroxetine compositions
compositions
paraxetine
Prior art date
Application number
BR9806754-0A
Other languages
English (en)
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700692.8A external-priority patent/GB9700692D0/en
Priority claimed from GBGB9714873.8A external-priority patent/GB9714873D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9806754A publication Critical patent/BR9806754A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO PAROXETINE". Trata-se de um cloridrato de paraxetine é obtido em forma facilmente solúvel e de escoamento livre (apropriada para preparação de formulações sólidas ou soluções aquosas, apropriadas para uso parenteral) ou por secagem espargimento de soluções de hemiidrato de paroxetine ou outras formas amorfa/solvato/hidrato/anidrato.
BR9806754-0A 1997-01-15 1998-01-12 Composições paroxetine. BR9806754A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9700692.8A GB9700692D0 (en) 1997-01-15 1997-01-15 Novel process and compound
GBGB9714873.8A GB9714873D0 (en) 1997-07-15 1997-07-15 Novel process and compound
PCT/GB1998/000081 WO1998031365A1 (en) 1997-01-15 1998-01-12 Paroxetine compositions

Publications (1)

Publication Number Publication Date
BR9806754A true BR9806754A (pt) 2000-03-14

Family

ID=26310796

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806754-0A BR9806754A (pt) 1997-01-15 1998-01-12 Composições paroxetine.

Country Status (21)

Country Link
US (1) US20010049442A1 (pt)
EP (1) EP0952831A1 (pt)
JP (1) JP2001508460A (pt)
KR (1) KR20000070151A (pt)
CN (1) CN1249686A (pt)
AP (1) AP9901604A0 (pt)
AU (1) AU730532B2 (pt)
BG (1) BG103648A (pt)
BR (1) BR9806754A (pt)
CA (1) CA2277480A1 (pt)
EA (1) EA002034B1 (pt)
HU (1) HUP0000960A3 (pt)
ID (1) ID23250A (pt)
IL (1) IL130856A (pt)
NO (1) NO993460L (pt)
NZ (1) NZ336587A (pt)
OA (1) OA11077A (pt)
PL (1) PL334568A1 (pt)
SK (1) SK95099A3 (pt)
TR (1) TR199901622T2 (pt)
WO (1) WO1998031365A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
TR200100444T2 (tr) * 1998-08-07 2001-07-23 Smithkline Beecham P.L.C. Paroksetin Hidroklorid'in bir kristalin olmayan anhidrat formunun hazırlanma yöntemi
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
JP4854115B2 (ja) 1999-03-12 2012-01-18 エイシカ ファーマシューティカルス リミテッド 無水パロキセチン用安定製剤形
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
PT1109806E (pt) 1999-07-01 2004-02-27 Italfarmaco Spa Complexos de paroxetina com ciclodextrinas ou derivados de ciclodextrinas
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
IL154422A0 (en) * 2000-08-28 2003-09-17 Synthon Bv Paroxetine compositions and processes for making the same
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
CA2277480A1 (en) 1998-07-23
EP0952831A1 (en) 1999-11-03
PL334568A1 (en) 2000-03-13
SK95099A3 (en) 2000-01-18
WO1998031365A1 (en) 1998-07-23
JP2001508460A (ja) 2001-06-26
NO993460L (no) 1999-09-14
CN1249686A (zh) 2000-04-05
AP9901604A0 (en) 1999-09-30
HUP0000960A2 (hu) 2001-02-28
AU5567398A (en) 1998-08-07
OA11077A (en) 2003-03-13
US20010049442A1 (en) 2001-12-06
BG103648A (en) 2000-04-28
KR20000070151A (ko) 2000-11-25
NO993460D0 (no) 1999-07-14
IL130856A (en) 2001-09-13
HUP0000960A3 (en) 2001-04-28
EA199900655A1 (ru) 2000-02-28
ID23250A (id) 2000-03-30
TR199901622T2 (xx) 1999-09-21
AU730532B2 (en) 2001-03-08
NZ336587A (en) 2001-01-26
EA002034B1 (ru) 2001-12-24
IL130856A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
BR9806754A (pt) Composições paroxetine.
CA2422374A1 (en) Purine derivatives
BG107171A (en) Purine derivatives
EP1109542A4 (en) NITROSED AND NITROSYLATED ANTAGONISTS OF THE ALPHA ADRENERGIC RECEPTOR, COMPOSITIONS AND USES THEREOF
BG106567A (en) Purine derivatives
DK1757606T3 (da) Anvendelse af xanthinderivater som l gemidler samt fremgangsm de til deres fremstilling
BR0104326B1 (pt) ôcomposição aquosa de revestimentoö.
HUP0103767A3 (en) Use of estrogen agonist/antagonist for preparation of pharmaceutical compositions available for treating osteoarthritis
WO2001060835A8 (en) Purine derivatives
MY136242A (en) Purine derivatives
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
HU0000697D0 (en) Use of stilbene derivates substituted in position 3, as deodorant active agents in cosmetic compositions
BR0013131B1 (pt) "processo para a preparação de boehmita microcristalina contendo um adtivo homogeneamente dispersado".
HK1042720B (zh) 瀝青改性用共聚物及瀝青組合物
BR0011831A (pt) Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos
IL151369A (en) Use of tgf-beta antagonist for the preparation of pharmaceuticals
GEP20094697B (en) Condensed purine derivatives as a1 adenosine receptor antagonists
BR9909486A (pt) Compostos calcilìticos
HUP0103431A3 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
BRPI0406832A (pt) Método de reduzir o crescimento de pêlos em um ser humano, uso de um conjugado de alfa-difluorometilornitina ou um sal farmaceuticamente aceitável do mesmo, composto, composição, e, uso de um composto
BR0208169A (pt) Composto quìmicos
BR0317623A (pt) Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram
NO20004144D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse som takykinin reseptor antagonister
BR9816029A (pt) Composições detergente

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1887 DE 06/03/2007.